This peptide is a tyrosinase epitope recognized by HLA-A24 restricted, tumor-infiltrating lymphocytes (TIL). Therefore it represents a reagent that may be used to generate melanoma-specific T cells for adoptive immunotherapy, as well as in peptide vaccines for HLA-A24+ melanoma patients. Kang, X; et al., J. Immunol., 155, 1343 (1995).
M.W.: 1186.44
